A commentary in the December 2009 issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen – the influenza virus – and its impact on decisions about how best to protect healthcare workers (HCWs).
Infectious diseases specialist Leonard Mermel, DO, medical director of infection control for Rhode Island Hospital, looks at the ongoing debate in light of the H1N1 pandemic, what past research tells us about the spread of influenza, and what is missing in the debate. His commentary is currently available in an online first edition.
Mermel, who is also a professor of medicine at the Warren Alpert Medical School of Brown University and a member of the University Medicine Foundation, says, "There is ongoing debate regarding influenza transmission and how best to mitigate risk of disease acquisition among healthcare workers. For no other common infectious disease is there such varied opinion, reflecting gaps in our knowledge about a common human pathogen."
Mermel points out five variables in preventing the transmission of the virus to HCWs: the dynamics of disease transmission; the availability of personal protective equipment (PPE); compliance among HCWs in the use of PPE; cost of PPE; and immune status of HCWs.
He notes that in two studies, one already published and one recently presented at the Infectious Diseases Society of America annual meeting, researchers found no statistically significant reduction in influenza-like illness among HCWs wearing N95 respirators compared with surgical masks.
Mermel points out that there is tremendous variability in the bioaeorosols produced by influenza-infected patients. He suggests that the inability to easily identify those individuals who produce large amounts of bioaerosols (i.e., superspreaders) is "The Achilles' heel of infection control" and he says, "Our limited understanding of such events leaves us vulnerable since we cannot predict which influenza-infected person is a superspreader."
Mermel notes the paramount importance of source control (i.e., influenza-infected patients wearing surgical masks, as tolerated) to minimize risk of transmission to HCWs. Mermel also refers to the risk of HCW-to-HCW influenza transmission if influenza-infected HCWs work while ill.
As a physician, Mermel believes that, "Science will guide us as we care for patients infected with H1N1 2009 but a lack of attention to our understanding of the transmission of human influenza has left us debating which procedures create influenza superspreading events, what is appropriate personal protective equipment, use of suboptimum engineered respirators that need fit testing and are poorly tolerated for prolonged use, and limited industrial capacity to meet our needs. For now, infection-control experts at each institution must weigh the variables noted to establish not only what is best, but what is realistic in reducing risk to their staff, their visitors, and their patients."
Mermel is a past president of the Society for Healthcare Epidemiology of America (SHEA).
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.